The rise of copyright’s blockbuster initially drove a surge for major pharmaceutical companies, but recent developments present a complicated outlook for shareholders. Off-patent competitors are eroding profits, and https://aliciaqxno680342.look4blog.com/79009912/viagra-and-big-pharma-a-risky-play